TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-25 06:07 am Sale |
2021-10-19 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
TAKEDA PHARMACEUTICAL CO LTD | 530,562 1.700% |
-1,328,589 (-71.46%) |
Filing |
| 2021-01-27 06:02 am Unchanged |
2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
TAKEDA PHARMACEUTICAL CO LTD | 1,859,151 7.200% |
0 (Unchanged) |
Filing |